Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AVICENNA CURA AS
AS
Active
Org 929234022
Snølia 7, 1470 Lørenskog
Activities of employment placement agencies · NACE 7810
Est. 2022
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 46K
-93% vs 2023
EBITDA margin
100.0%
+194% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
NOK 46K
+166% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 46K
-93%
EBITDA
NOK 46K
+194%
Net profit
NOK 46K
+166%
Total assets
NOK 0
-100%
Equity
NOK 0
+100%
Employees
2
—
Company information
Legal name
AVICENNA CURA AS
Org number
929234022
Legal form
Aksjeselskap
NACE code
7810 · Activities of employment placement agencies
Founded
20. mai 2022
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Yaruk tariq malik
Company purpose
Bemanning.
Contact
Address
Snølia 7, 1470 Lørenskog
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of employment placement agencies
Companies in Lørenskog
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
658
46
Staff expenses
−0
−438
−0
EBITDA
−7
−49
46
Depreciation & amort.
−0
−0
−0
EBIT
−7
−49
46
Net financials
0
−11
0
Profit before tax
−7
−60
46
Tax
−0
9
−0
Net profit
−7
−69
46
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
24
28
0
Equity
23
−46
0
Long-term debt
0
0
0
Short-term debt
1
74
0
Total debt
1
74
0
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2022
2024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2022
2024
Return on equity
4609200.0%
This company
18.4%
Market median
+25049900% vs market
2022
2024
Net profit margin
100.0%
This company
8.1%
Market median
+1135% vs market
2022
2024
Asset turnover
46092.00×
This company
1.12×
Market median
+4115257% vs market
2022
2024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
YT
Yaruk Tariq Malik
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SS
Shabdiz Seyed Milad Madani
Chairman
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ytm Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Ytm Holding As
AVICENNA CURA AS
(this company)
Board network connections
Board members of AVICENNA CURA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Yaruk Tariq Malik
Chief Executive Officer
0 companies
Shabdiz Seyed Milad Madani
Chairman
0 companies